Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Report: Manufacturing Mergers Down In Third Quarter

By Pharmaceutical Processing | November 5, 2015

Mergers and acquisitions in the industrial manufacturing sector declined in the third quarter, according to the latest analysis from PwC US.

The company’s Assembling Value report—which examines announced deals valued at more than $50 million—said that 55 large transactions were executed between July and September with a combined value of $20.9 billion.

Although it was the sixth consecutive quarter with more than 50 deals, both numbers were down compared to the second quarter’s 66 deals worth $28.2 billion.

The latest quarter saw four deals worth more than $1 billion each—up from three in the previous quarter—but the combined value of those deals fell from $16 billion to $9.8 billion.

PwC analysts said that despite the declining numbers, manufacturers continued to assess their portfolios, add scale and exit non-core operations.

Read more: Manufacturers must maintain focus on core concepts despite rapid change.

“The continued interest in deal-making in the third quarter has been especially notable given weakening global manufacturing activity and increased uncertainty regarding the economic outlook,” said Bobby Bono, PwC’s U.S. industrial manufacturing leader.

Strategic investors—rather than financial buyers—accounted for about two-thirds of deals in the latest quarter, particularly by seeking acquisitions in the higher growth automotive, aerospace and electrical markets.

Strategic buyers also continued to streamline their operations. Divestitures accounted for 27 percent of transactions in the quarter.

“As we enter the final quarter of the year, we expect the level of deal activity to remain stable as mixed global economic results steer manufacturing executives toward further portfolio reshuffling,” Bono said.

The report said that Asia and Oceania accounted for 62 percent of third quarter mergers, while the U.S. share of merger activity remained unusually low.

Analysts, however, said that U.S. activity could pick up as the strong dollar increases interest in outbound deals.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE